Table 3 Factors associated with the likelihood of SVR. Crude and adjusted Odds Ratios (O.R.) derived by multiple logistic regression analysis
From: HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Crude O.R. (95% CI) | Adjusted O.R. | (C.I. 95%) | |
|---|---|---|---|
HCV-RNA ≤ 5.6 log10 IU/ml | 2.9 (1.8-5.1) | 3.2 | (2.7-6.9) |
≤ S3* | 3.8 (2.0-7.3) | 3.8 | (3.2-7.4) |
Subtype 1a | 1.9 (1.2-2.9) | 1.8 | (1.4-4.1) |
Age | 7.4 (0.9-40.0) | 7.0 | (1.1-21.2) |
< 50 | |||
> 50 | |||
BMI | 1.7 (1.0-2.8) | 1.4 | (0.8-2.5) |
< 25 | |||
> 25 | |||
ALT | 1.9 (1.2-3.0) | 2.1 | (1.3-3.5) |
< 100 | |||
> 100 | |||
Sex | 1.1 (0.7-1.7) | 1.3 | (0.8-2.2) |
RVR | 21.0 (11.5-38.3) | 3.2 | (1.3-7.7) |